Company: Ginkgo Bioworks
Industry: Biotech
Valuation: $15B
Headquarters: Boston, MA
Investors: Bill Gates, Viking Global
IPO Prediction: Already public (2021)
Notes: Interesting as a benchmark biotech unicorn. SPAC IPO.
Tags: biotech, SPAC, US
